Survival benefits of chemotherapy for unresectable biliary tract cancer - A multicenter retrospective analysis

Akihiro Funakoshi, Hikoyuki Horiuchi, Terufumi Sakai, Toshihiko Miyahara, Toru Muranaka, Masashi Nakamura, Kazuhiro Mizumoto, Toshiharu Ueki, Akinobu Taketomi, Hiroya Yamaguchi, Toshihiko Sumii, Tetsuhide Ito

研究成果: Contribution to journalArticle査読

抄録

There is no agreement on the standard chemotherapeutic regimen for biliary tract cancer (BTC), although multi-drug regimens such as gemcitabine and/or S-1 have been tested in clinical trials. This study retrospectively reviewed data from patients with BTC who were seen at hospitals in the Kitakyushu and Fukuoka areas between 2005 and 2006, and examined the effect of systemic chemotherapy regimen on survival benefits in patients with unresectable BTC. Chemotherapy may benefit patients with BTC any age group, regardless of the primary site.

本文言語英語
ページ(範囲)2875-2879
ページ数5
ジャーナルJapanese Journal of Cancer and Chemotherapy
37
13
出版ステータス出版済み - 12 2010

All Science Journal Classification (ASJC) codes

  • 医学(全般)

フィンガープリント

「Survival benefits of chemotherapy for unresectable biliary tract cancer - A multicenter retrospective analysis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル